Quoin Pharmaceuticals Ltd.
Sector: Healthcare & Life Sciences
About Quoin Pharmaceuticals Ltd.
| Quoin Pharmaceuticals Toggle navigation Who We Are Timeline/History Leadership Board Partners Pipeline Pipeline Netherton Syndrome Indications Patients & Families Clinical Trial FAQs Investors Company Overview News & Events Stock information Financial Information Corporate Governance IR --> Rare diseases are only rare if you don’t live with one. ® Today, rare diseases affect approximately 300 million people worldwide. While the diseases themselves are uncommon, the challenges associated with living with one most definitely are not.
Products
QRX003 Netherton Syndrome* Peeling Skin Syndrome** SAM Syndrome Ichthyosis*** QRX008 Scleroderma QRX009 Microcystic Lymphatic Malformations, Venous Malformations, Angiofibroma and others.
Quoin’s team is relentlessly focused on developing and commercializing innovative treatments for rare and orphan diseases, for which none exists today. Their pipeline comprises three unique products that collectively have the potential to target a broad number of indications, including Netherton Syndrome, Scleroderma, Peeling Skin Syndrome, Ichthyosis, Microcystic Lymphatic Malformations, Angiofibroma, and others.